Ads
related to: moderna
Search results
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 11 hours agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
Dow Jones Today: Stocks Mixed As Dow on Track To Extend Winning Streak to Eight Consecutive Sessions
Investopedia· 6 hours agoModerna (MRNA) slid 4% as the biotech’s effort to move beyond just a COVID-19 vaccine was stalled...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 10 hours agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 12 hours agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 11 hours ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 1 day agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 1 day agoOn Thursday, Deutsche Bank (ETR:DBKGn) revised its price target for Moderna (NASDAQ:MRNA) shares,...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 19 hours agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Analysts Are Updating Their Moderna, Inc. (NASDAQ:MRNA) Estimates After Its First-Quarter Results
Simply Wall St. via Yahoo Finance· 7 days agoModerna, Inc. (NASDAQ:MRNA) just released its quarterly report and things are looking bullish....
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 17 hours agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...